EurekAlert! -
6 Jan 2015 07:00
(American Associates, Ben-Gurion University of the Negev) In the study, mice were directly infected with highly lethal live bacteria, sepsis and peritonitis. The initial aim was to exclude the possibility that AAT, might worsen infections in patients who are being treated with the drug. AAT is currently being used to treat new clinical indications like type 1 diabetes, emphysema and graft versus host disease.Instead, the BGU research group unexpectedly discovered that the treated mice combatted ...
Share this Article